COVID-19: Cutaneous manifestations and issues related to dermatologic care

Posted on | Posted on John Murphy | Leave a Comment on COVID-19: Cutaneous manifestations and issues related to dermatologic care

Authors: Steven R Feldman, MD, PhD, Esther E Freeman, MD, PhD Literature review current through: Jul 2021. | This topic last updated: Apr 06, 2021. INTRODUCTION Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), raises many critical issues in dermatology and dermatologic care. Addressing these issues is necessary, yet also challenging, because there are […]

Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report

Posted on | Posted on John Murphy | Leave a Comment on Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report

Authors: Dmitriy A. Gagarkin, Keith E. Dombrowski, Keyur B. Thakar & John C. DePetrillo  Journal of Medical Case Reports volume 15, Article number: 219 (2021)  Abstract Background Coronavirus disease 2019 (COVID-19) is a global pandemic. The disease, typically characterized by bilateral pulmonary infiltrates and profound elevation of inflammatory markers, can range in severity from mild or asymptomatic illness to a lethal cytokine storm and […]

COVID-19 and emerging spinal cord complications: A systematic review

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and emerging spinal cord complications: A systematic review

Authors: Ritwick Mondal,aShramana Deb,bGourav Shome,cUpasana Ganguly,aDurjoy Lahiri,a,d,⁎ and Julián Benito-Leóne,f,g,⁎⁎ Mult Scler Relat Disord. 2021 Jun; 51: 102917.Published online 2021 Mar 21. doi: 10.1016/j.msard.2021.102917 Abstract Background Spinal cord complications associated with coronavirus infectious disease of 2019 (COVID-19) are being widely reported. The purpose of this systematic review was to summarize so far available pieces of evidence documenting de novo novel severe acute […]

Delta variant: What is happening with transmission, hospital admissions, and restrictions?

Posted on | Posted on John Murphy | Leave a Comment on Delta variant: What is happening with transmission, hospital admissions, and restrictions?

Authors: Elisabeth Mahase BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n1513 (Published 15 June 2021)Cite this as: BMJ 2021;373:n1513 Are covid-19 hospital admissions increasing? Yes. The number of new cases of covid-19 has been rising in the UK for the past few weeks, and admissions of patients to hospital are following suit. As of 9 June the number of people in hospital each day with […]

The origin of SARS-CoV-2 furin cleavage site remains a mystery

Posted on | Posted on John Murphy | Leave a Comment on The origin of SARS-CoV-2 furin cleavage site remains a mystery

Authors: By Dr. Liji Thomas, MD Feb 17 2021 The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has largely defied attempts to contain its spread by non-pharmaceutical interventions (NPIs). With the massive loss of life and economic damage, the only way out, in the absence of […]

Comparison between RT-qPCR for SARS-CoV-2 and expanded triage in sputum of symptomatic and asymptomatic COVID-19 subjects in Ecuador

Posted on | Posted on John Murphy | Leave a Comment on Comparison between RT-qPCR for SARS-CoV-2 and expanded triage in sputum of symptomatic and asymptomatic COVID-19 subjects in Ecuador

Authors: Ariel Torres, Martha Fors, Tamaris Rivero, Karina Pantoja & Santiago Ballaz  BMC Infectious Diseases volume 21, Article number: 558 (2021)  Abstract Background The quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) effectively detects the SARS-COV-2 virus. SARS-CoV-2 Nevertheless, some critical gaps remain in the identification and monitoring of asymptomatic people. Methods This retrospective study included 733 asymptomatic and symptomatic COVID-19 subjects, who were submitted to the […]

Let’s Stop Pretending About the Covid-19 Vaccines

Posted on | Posted on John Murphy | Leave a Comment on Let’s Stop Pretending About the Covid-19 Vaccines

Authors: .By Buzz Hollander, MD As a family physician, I spend my days dispensing advice. I mean, there’s the occasional cast, skin biopsy, or shot, but most of my patients are seeing me for medical counsel. Never have I been asked about one subject so much as the Covid-19 vaccines, and never have I seen so […]

FDA grants full approval to Pfizer-BioNTech’s Covid shot, clearing path to more vaccine mandates

Posted on | Posted on John Murphy | Leave a Comment on FDA grants full approval to Pfizer-BioNTech’s Covid shot, clearing path to more vaccine mandates

Authors: Berkeley Lovelace Jr. @BERKELEY JR PUBLISHED MON, AUG 23 20219:37 AM EDTUPDATED AN HOUR AGO KEY POINTS The FDA granted Pfizer and BioNTech full U.S. approval of their Covid-19 vaccine. The move may encourage some unvaccinated Americans to get the shots as well as give more private businesses across the nation greater confidence to […]

How Manufacturers can Keep Employees Safe From COVID-19

Posted on | Posted on John Murphy | Leave a Comment on How Manufacturers can Keep Employees Safe From COVID-19

Authors: Soumi Eachempati APR 27, 2021 A list of actions employers can take to maintain a healthy workforce and compliance. While the COVID-19 pandemic is challenging for all organizations, manufacturers have had the especially daunting task of keeping their employees safe while keeping their businesses open. In the last 13 months, hundreds of deaths and […]

Review of COVID-19’s long-term effects

Posted on | Posted on John Murphy | Leave a Comment on Review of COVID-19’s long-term effects

Authors: By Dr. Ramya Dwivedi, Ph.D. Coronavirus disease 2019 (COVID-19) has caused over 3.75 million deaths worldwide through infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In Canada, COVID-19 has accounted for over 1.4 million infections and over 25,000 deaths. Acute COVID-19 illness typically lasts two to six weeks; however, some patients have reported debilitating […]